

Please log in to write SOLARIS review.
CLASSIFICATION: BETA-2 AGONIST (FAT BURNER)
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS × 40 MCG
ACTIVE HALF-LIFE: 36–48 HOURS
DOSAGE: MEN 120–140 MCG/DAY, WOMEN 80–100 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 40-160 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 PILLS x 40 MCG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 40-160 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS x 40 MCG
ACTIVE HALF-LIFE: ~36 HOURS
DOSAGE: MEN 20–120 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
LABORATORY TESTED: VIEW LAB RESULTS